Abiopharma

FuelCell Energy Secures $49 Million in EXIM Financing to Advance U.S. Clean Energy Exports

Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves' Disease

HONEYWELL TECHNOLOGIES TO RELEASE SECOND QUARTER FINANCIAL RESULTS, DISCUSS 2026 OUTLOOK AND HOLD ITS INVESTOR CONFERENCE CALL ON THURSDAY, JULY 23

Streamex Corp. Brings Yield-Bearing Gold (GLDY) to Traditional Brokerage Accounts Through Collaboration with Siebert Financial and tZERO

Twin Disc, Inc. Joins Russell 2000® and Russell 3000® Indexes

Zura Bio Exceeds Enrollment Target in Both Hidradenitis Suppurativa (HS) & Systemic Sclerosis (SSc) Phase 2 Studies and Expands Tibulizumab Program

Almonty Industries Joins Large-Cap Russell 1000® Index and Broad-Market Russell 3000® Index

Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves Disease

Valmont Releases 2026 Sustainability Report

Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer